Verdad Advisers »

Tscan Therapeutics shares owned by Verdad Advisers

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Verdad Advisers from 13F filings

Historical chart of Verdad Advisers investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Verdad Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Verdad Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $135k 134k 1.01

More positions owned by Verdad Advisers

Belite Bio Sponsored Ads (BLTE)
State Street Corporation (STT)
Autohome Sp Ads Rp Cl A (ATHM)
Revolution Medicines (RVMD)
Zymeworks Del (ZYME)
Cal Maine Foods Com New (CALM)
Zoom Communications Cl A (ZM)
California Res Corp Com Stock (CRC)
Tenax Therapeutics Com New (TENX)
ACADIA Pharmaceuticals (ACAD)
Par Pac Holdings Com New (PARR)
Johnson & Johnson (JNJ)
Micron Technology (MU)
Nurix Therapeutics (NRIX)
Comcast Corp Cl A (CMCSA)

View all positions for Verdad Advisers

Top funds holding Tscan Therapeutics

Lynx1 Capital Management
BVF
Baker Bros. Advisors
Vanguard Capital Management
BlackRock
Millennium Management
Renaissance Technologies
Deer Management
Two Sigma Investments
Standard Life Aberdeen
Jacobs Levy Equity Management
DC Funds
Geode Capital Management
GSA Capital Partners
D. E. Shaw & Co

View all funds holding Tscan Therapeutics